ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "ExamWorks Group, Inc." (EXAM) Report Updated: Jul 28, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"ExamWorks Group, Inc." (EXAM)

Rating: Buy Volatility: Moderate
Total Grade: B Industry: Health Care Providers & Services
Competitors: MCK, SEM, CAH, CHE

Stock Analysis

Rating: Monthly View

A
B
C
D
F
July August September October November December January February March April May June

Rating: Weekly View

This Week: B down no change
Last Week: B same no change
Two Weeks Ago: B up no change
service keys

"ExamWorks Group, Inc."© quotemedia

Company Profile

ExamWorks Group, Inc., together with its subsidiaries, provides independent medical examinations (IME), peer and bill reviews, and related services in the United States, Canada, and the United Kingdom. Its IME services are used by clients to confirm the veracity of claims by sick or injured individuals for workers’ compensation, automotive, personal injury liability, and disability insurance coverage. The company also offers peer review services, including medical record reviews, nurse file reviews, and utilization reviews by members of its medical panel to provide medical opinion of a claimant’s condition and treatment; bill review services, such as physician and hospital bill reviews, and surgical cost estimates; and other IME related services comprising litigation support, medical record retrieval, and administrative support services. ExamWorks Group, Inc. provides its services through its medical panel of independently contracted physicians and other medical providers. It serves property and casualty insurance carriers, law firms, third-party claim administrators, government agencies, and state funds. The company was founded in 2001 and is headquartered in Atlanta, Georgia.

Recent News: "ExamWorks Group, Inc."